Results 151 to 160 of about 10,401 (200)

Nasal Cytology Is Useful for Evaluating and Monitoring the Therapeutic Response to Biologics in Chronic Rhinosinusitis with Nasal Polyposis. [PDF]

Biomedicines
Piatti G, Battilocchi L, Cozzi A, Gaini LM, Aldè M, Pignataro L, Torretta S.   +6 more
europepmc   +1 more source

Kimura Disease: Retrospective Analysis of 53 Cases and Three Mepolizumab-Responsive Cases. [PDF]

J Inflamm Res
Zhu W, Zhang L, Zhang J, Wang W, Xiang Y, He D, Shi J, Liang Y, Shi Y, Ning X, Jin M, Ye L.   +11 more
europepmc   +1 more source

FDA-Approved Biologics for CRSwNP: A Five-Year Analysis of the FDA Adverse Event Reporting System. [PDF]

Laryngoscope Investig Otolaryngol
Duggal R, Chaaban MR.
europepmc   +1 more source

Kimura Disease With Eosinophilic Granulomatosis With Polyangiitis Successfully Treated by Mepolizumab. [PDF]

Clin Case Rep
Du W, Dai R, Chen X, Tang W.
europepmc   +1 more source

Analysis of Selected Serum Cytokines to Evaluate the Early Efficacy of Benralizumab, Dupilumab, and Mepolizumab in Severe Eosinophilic Asthma Treatment. [PDF]

Int J Mol Sci
Niemiec-Górska A, Labus Ł, Mielcarska S, Glück J, Czuba Z, Cyrnek M, Branicka O, Rymarczyk B, Gawlik R.   +8 more
europepmc   +1 more source

HEDGES co-prevents both SARS-CoV-2 and pandemic influenza infection in mice by rapid, durable co-production of twelve different anti-pandemic monoclonal antibodies. [PDF]

PLoS One
Mack M, Ye A, Ursu S, Ice R, Soroceanu L, Shoor S, McAllister S, Heath T, Handumrongkul C, Debs R.   +9 more
europepmc   +1 more source

Clinical outcomes after switching from omalizumab to anti-IL-5/IL-5R biologics in severe asthma: a retrospective cohort study. [PDF]

BMC Pulm Med
Akkuş FA, Çölkesen F, Önalan T, Gerek ME, Kılınç M, Arslan Ş.   +5 more
europepmc   +1 more source

Correction to "Kimura Disease With Eosinophilic Granulomatosis With Polyangiitis Successfully Treated by Mepolizumab". [PDF]

Clin Case Rep
europepmc   +1 more source